InvestorsHub Logo
Followers 14
Posts 733
Boards Moderated 0
Alias Born 12/09/2013

Re: None

Wednesday, 09/07/2022 10:26:46 AM

Wednesday, September 07, 2022 10:26:46 AM

Post# of 2983
https://ir.enanta.com/news-releases/news-release-details/new-preclinical-data-edp-235-enantas-oral-coronavirus-protease

For me this seems one more step validating EDP-325. As J.Luly Enanta CEO addressed some of the potential differences between the Enanta antiviral and it's Pfizer competitor Paxlovid we may soon see some of those differences quantified in a medical conference in about 6 weeks.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News